NovaLife, Inc. Posts Medical Results on Factor4 Weight Control
NovaLife has posted twelve medical articles on the benefits of its flagship product, Factor4 Weight Control® on comorbidities which are associated with obesity and the Metabolic Syndrome. These case studies include type-2 diabetes, lipid disorders, cardiovascular disease, inflammatory conditions, autoimmune diseases, menopause/andropause, depression, anxiety, chronic stress, and sleep deprivation.
View full press release